Bone marrow metastasis in nasopharyngeal cancer: Early detection using EBER1 in situ hybridization

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 885-888

  Chen, Tsai Yun ^a   Tsai, Sen Tien ^a   Jin, Ying Tai ^a   Su, Wu Chou ^a   Tsao, Chao Jung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bone marrow metastasis; EBER1; In situ hybridization; Nasopharyngeal carcinoma

Indexed keywords

CYTOKERATIN; VIRUS RNA;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOPENIA; DIAGNOSTIC ACCURACY; DISSEMINATED INTRAVASCULAR CLOTTING; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MYELOPHTHISIC ANEMIA; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL;

ADULT; BONE MARROW NEOPLASMS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; RNA, VIRAL;

EID: 0032955786     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Perez CA, Ackerman LV, Mill WB, Ogura JH, Powers WE: Cancer of the nasopharynx: Factors influencing prognosis. Cancer 24: 1-17, 1969.
2. Thompson RW, Dogget RLS, Basshaw MA: Ten-year experience with linear accelerator irradiation of cancer of the nasopharynx. Radiology 97: 149-55, 1970.
3. Moench HC, Phillips TL: Carcinoma of the nasopharynx: Review of 146 patients with emphasis on radiation dose and time factor. Am J Surg 124: 515-18, 1972.
4. Hoppe RT, Coffinet DR, Bagshaw MA: Carcinoma of the nasopharynx: Eighteen years' experience with megavoltage radiation therapy. Cancer 37: 2605-12, 1976.
5. Bedwineck JM, Perez CA, Keys DJ: Analysis of failures after definitive irradiation of epidermoid carcinoma of the nasopharynx. Cancer 45: 2725-9, 1980.
6. Mesic JB, Fletcher GH, Goepfert H: Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 7: 447-53, 1981.
7. Sham JST, Choy D: Prognostic factors of nasopharyngeal carcinoma: A review of 759 patients. Br J Radiol 63: 51-8, 1990.
8. Micheau C, Boussen H, Klifanienko G, Cvitkovic E, Stosic S, Chwaab G, et al: Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type. Cancer 60-2459-64, 1987.
9. Sham JST, Chan LC, Loke SL, Choy D: Nasopharyngeal carcinoma: role of marrow biopsy at diagnosis. Oncology 48: 480-2, 1991.
10. Greco FA, Oldham RK. Small cell lung cancer. N Engl J Med 301: 355-8, 1979.
11. Schminke A: Uber. Lymphoepitheliale geschwulste beiter. Pathol Anat 58: 161-70, 1921.
12. Ho HC: Genetic and environmental factors in nasopharyngeal carcinoma. In: Recent Advances in Human Tumor Virology and Immunology. Tokyo, Japan, University of Tokyo Press, 1971, pp 275-95.
13. Henle W, Henle G: The association of Epstein-Barr virus with nasopharyngeal carcinoma. In: Nasopharyngeal Carcinoma. (Grundmann E, Krueger GRF, Ablashi DV, eds.) Cancer Campaign, Stuttgart, New York, NY, Gustav Fischer Verlag, 1981, pp 1-6.
14. Zur Hausen H, Schulte-holthausen H, Klein G, Henle W, Henle G, Clifford P, et al: EBV DNA in biopsies of Burkitt's tumors and anaplastic carcinomas of the nasopharynx. Nature 228: 1056-8, 1970.
15. Wu TC, Mann RB, Epstein JI, Macmabon E, Lee WA, Charache P, et al: Abundant expression of EBER 1 small nuclear RNA in nasopharyngeal carcinoma, a morphologically distinctive target for detection of Epstein-Barr virus in formalin fixed paraffin-embedded carcinoma specimens. Am J Pathol 138: 1461-9, 1991.
16. Khan G, Coates PJ, Kangro HO, Slavin G: Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridization with oligonucleotide probes. J Clin Patol 45: 616-20, 1992.
17. Glickman JN, Howe JG, Steitz JA: Structural analysis of EBER-1 and EBER-2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol 62: 901-11, 1989.
18. Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Dallenbach F, Parwaresch MR, Stein H: Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphomas of angioimmunoblastic lymphadenopathy type. Blood 80: 1804-12, 1992.
19. Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ: Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphomas. Blood 79: 1789-95, 1992.
20. Tsai ST, Jin YT, Su IJ: Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization: a correlation with WHO histologic subtypes. Cancer 77: 231-6, 1996.
21. Tsai ST, Jin YT, Wu TC: Synthesis of PCR-derived digoxigeninlabelled DNA probes for in situ detection of EBERs in Epstein-Barr virus-infected cells. J Virol Methods 54: 67-74, 1995.
22. Cvitkovic E, Bachouchi M, Boussen H, Busson P, Rousselet G, Mahjoubi R, et al: Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: A review of 255 consecutive cases. J Clin Oncol 11: 2434-42, 1993.
23. Zen H, Jame JM, Chang AYC, Li WY, Law CK, Chen KY, et al: Nasopharyngeal carcinoma with bone marrow metastasis. Am J Clin Oncol 14: 66-70, 1991.
24. Fidler IJ, Hart IR: Principle of cancer biology: cancer metastasis. In-Cancer: principle and practice of oncology. 2nd ed. (DeVita VT, Hellman S, Rosenberg SA, eds). Philadelphia, J.B. Lippincott, 1985; pp113-24.
25. Gugliotta P, Botta G, Bussolati G: Immunocytochemical detection of tumor markers from carcinoma of the breast. Histochem J 13: 953-9, 1981.
26. Redding WH, Monaghan P, Imrie SF, Ormerod MG, Gazet JC, Coombs RC, et al: Detection of micrometastases in patients with primary breast cancer. Lancet 2: 1271-3, 1983.
27. Lindemann F, Schlimok G, dirschedl P, Witte F, Riethmuller G: Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 340: 685-9, 1992.
28. Hermanek P: pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 19: 184-190, 1995.
29. Shpall EJ, Jones RB: Release of tumor cells from bone marrow. Blood 83: 623-625, 1994.
30. Passos-Coelho J, Ross AA, Davis JM, et al: Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: Effect of ex vivo purging with 4-hydroyperoxycyclophosphamide. Cancer Res 54: 2366-2371, 1994.
31. Hay FG, Ford A, Leonard RCF: Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC). Int J Cancer 2: 8-10, 1988.
32. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475-482, 1994.